We have reported a tumor-rejection antigen, SART1 259 , possessing tumor epitopes capable of inducing cytotoxic T lymphocytes (CTLs) in epithelial-cancer patients. This study investigated the expression of SART1 259 antigen in brain tumors, to explore for a potential molecule for use in specific imm
The role of tumor rejection antigens in host antitumor defense mechanisms
β Scribed by Fiona A. Campbell; H. Paul Redmond; David Bouchier-Hayes
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 733 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
We investigated in breast cancers the expression of the SART-1 gene encoding tumor rejection antigens. SART-1 mRNA was expressed in all of the samples tested. The SART-1 800 antigen was detectable in 20 of 50 (40%) breast cancer tissues and all breast cancer cell lines tested, but not in normal brea
## Abstract We have attempted to determine what host mechanisms are responsible for inducing a rapid decrease in the number of Friend leukemia cells (FLC) in the peritoneal cavity of interferonβtreated mice. By injecting radiolabelled FLC, we showed that there was a greater loss of radioactivity fr